These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 6085438)
1. Monoclonal antibodies identify a strain-specific epitope on the HN glycoprotein of Newcastle disease virus strain Australia-Victoria. Iorio RM; Lawton KA; Nicholson PM; Bratt MA Virus Res; 1984 Oct; 1(7):513-25. PubMed ID: 6085438 [TBL] [Abstract][Full Text] [Related]
2. Genetic variation within a neutralizing domain on the haemagglutinin-neuraminidase glycoprotein of Newcastle disease virus. Iorio RM; Borgman JB; Glickman RL; Bratt MA J Gen Virol; 1986 Jul; 67 ( Pt 7)():1393-403. PubMed ID: 2425048 [TBL] [Abstract][Full Text] [Related]
3. Functional and neutralization profile of seven overlapping antigenic sites on the HN glycoprotein of Newcastle disease virus: monoclonal antibodies to some sites prevent viral attachment. Iorio RM; Glickman RL; Riel AM; Sheehan JP; Bratt MA Virus Res; 1989 Jul; 13(3):245-61. PubMed ID: 2475989 [TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies as functional probes of the HN glycoprotein of Newcastle disease virus: antigenic separation of the hemagglutinating and neuraminidase sites. Iorio RM; Bratt MA J Immunol; 1984 Oct; 133(4):2215-9. PubMed ID: 6470488 [TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies to the HN glycoprotein of Newcastle disease virus. Biological characterization and use for strain comparisons. Nishikawa K; Isomura S; Suzuki S; Watanabe E; Hamaguchi M; Yoshida T; Nagai Y Virology; 1983 Oct; 130(2):318-30. PubMed ID: 6196907 [TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibody routinely used to identify avirulent strains of Newcastle disease virus binds to an epitope at the carboxy terminus of the hemagglutinin-neuraminidase protein and recognizes individual mesogenic and velogenic strains. Alamares JG; Li J; Iorio RM J Clin Microbiol; 2005 Aug; 43(8):4229-33. PubMed ID: 16081986 [TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies to newcastle disease virus: delineation of four epitopes on the HN glycoprotein. Iorio RM; Bratt MA J Virol; 1983 Nov; 48(2):440-50. PubMed ID: 6194312 [TBL] [Abstract][Full Text] [Related]
8. Identification of a potential neutralizing linear epitope of hemagglutinin-neuraminidase in Newcastle disease virus. Jin Z; Wei Q; Bi Y; Li Y; Huo N; Mou S; Wang W; Liu H; Yang Z; Chen H; Xiao S Virol J; 2021 Jan; 18(1):8. PubMed ID: 33407693 [TBL] [Abstract][Full Text] [Related]
9. Characterization of reference strains of Newcastle disease virus (NDV) and NDV-like isolates by monoclonal antibodies to HN subunits. Ishida M; Nerome K; Matsumoto M; Mikami T; Oya A Arch Virol; 1985; 85(1-2):109-21. PubMed ID: 2409954 [TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies reveal extensive antigenic differences between the hemagglutinin-neuraminidase glycoproteins of human and bovine parainfluenza 3 viruses. Ray R; Compans RW Virology; 1986 Jan; 148(1):232-6. PubMed ID: 2417412 [TBL] [Abstract][Full Text] [Related]
11. Mapping of three antigenic sites on the haemagglutinin-neuraminidase protein of Newcastle disease virus. Yusoff K; Nesbit M; McCartney H; Emmerson PT; Samson AC Virus Res; 1988 Nov; 11(4):319-33. PubMed ID: 2464879 [TBL] [Abstract][Full Text] [Related]
12. Neutralization of Newcastle disease virus by monoclonal antibodies to the hemagglutinin-neuraminidase glycoprotein: requirement for antibodies to four sites for complete neutralization. Iorio RM; Bratt MA J Virol; 1984 Aug; 51(2):445-51. PubMed ID: 6205169 [TBL] [Abstract][Full Text] [Related]
13. Neutralizing activity of the antibodies against two kinds of envelope glycoproteins of Sendai virus. Tozawa H; Komatsu H; Ohkata K; Nakajima T; Watanabe M; Tanaka Y; Arifuku M Arch Virol; 1986; 91(1-2):145-61. PubMed ID: 2428330 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of the use of monoclonal antibodies to hemagglutinin and fusion glycoproteins of Newcastle disease virus for virus identification and strain differentiation purposes. Meulemans G; Gonze M; Carlier MC; Petit P; Burny A; Le Long Arch Virol; 1987; 92(1-2):55-62. PubMed ID: 2432855 [TBL] [Abstract][Full Text] [Related]
15. Identification of novel E347Q and G362K amino acid substitutions in HN neutralization epitope and major antigenic difference in novel sub-genotype VIIj isolates. Mayahi V; Esmaelizad M Acta Virol; 2017; 61(4):438-444. PubMed ID: 29186960 [TBL] [Abstract][Full Text] [Related]
16. Structural features unique to each of the three antigenic sites on the hemagglutinin-neuraminidase protein of Newcastle disease virus. Gotoh B; Sakaguchi T; Nishikawa K; Inocencio NM; Hamaguchi M; Toyoda T; Nagai Y Virology; 1988 Mar; 163(1):174-82. PubMed ID: 2450424 [TBL] [Abstract][Full Text] [Related]
17. The reactions of monoclonal antibodies with structural proteins of mumps virus. Orvell C J Immunol; 1984 May; 132(5):2622-9. PubMed ID: 6201553 [TBL] [Abstract][Full Text] [Related]
18. Parainfluenza virus type 2 haemagglutinin-neuraminidase glycoprotein characterized with monoclonal antibodies. Rydbeck R; Löve A; Orvell C J Gen Virol; 1988 Apr; 69 ( Pt 4)():931-5. PubMed ID: 2451708 [TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies specific for the hemagglutinin-neuraminidase protein define neutralizing epitopes specific for Newcastle disease virus genotype 2.VII from Egypt. Moharam I; Asala O; Reiche S; Hafez H; Beer M; Harder T; Grund C Virol J; 2021 Apr; 18(1):86. PubMed ID: 33902633 [TBL] [Abstract][Full Text] [Related]
20. The characterization of monoclonal antibodies to Newcastle disease virus. Russell PH; Griffiths PC; Goswami KK; Alexander DJ; Cannon MJ; Russell WC J Gen Virol; 1983 Sep; 64 (Pt 9)():2069-72. PubMed ID: 6193248 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]